The Clinical Effect of XTR Combined with Terbinafine in 46 Patients with Toenail Onychomycosis

牟萍,丁敏,安徐生,李晶冰,王艳
DOI: https://doi.org/10.13241/j.cnki.pmb.2012.36.018
2012-01-01
Abstract:Objective:To evaluate the clinical effect of XTR combined with Terbinafine on toenail onychomycosis.Methods:92 patients who were diagnosed toenail onychomycosis in Xuzhou Central Hosputal were enrolled in the sudy.They were randomly divided into the trial group and the control group,the trail group:patients were receiving oral Terbinafine(250mg qd) and XTR(2 capsules tid);the control group:patients were receiving oral Terbinafine(250 mg qd).One month for a period of treatment.Related indexs were tested three months later and recurrence rate was followed up twelve months later.The agreement also stipulated that patients return visit every two weeks,keep a record of safety.And no drug or treatment should be used during the observation periods.Results:The trail group:Among the 46 cases,34 patients were clinically cured,8 markedly improved,6 effective.The cure rate was 73.91%;5 patients relapsed after 12months;the recurrence rate is 10.87%.The control group:Among the 46 cases,29 patients were clinically cured,8 markedly improved,9 effective.The cure rate was 63.04%;15 patients relapsed after 12months;the recurrence rate is 32.60%.Adverse reaction:Gastrointestinal tract reaction or diarrhea turned up in the trail group but only gastrointestinal tract reaction in the control group,all these adverse reactions were temporary,tended to resolve when the drugs were stopped.Conclusion:The cure rate and recurrence rate in treatment group was obviously better than those in control group(P 0.05),showing the guiding function in instructing the clinical application.
What problem does this paper attempt to address?